XY028-140 | m-entrepreneurship.com

Product Name :
XY028-140

Search keywords :
XY028-140

drugId :
null

Target Vo:
Cyclin-dependent kinase 4

Target Vo Short Name :
CDK4

Moa_Name:
Cyclin-dependent kinase 4 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Icahn School Of Medicine At Mount Sinai

Active Company_Name :
Icahn School Of Medicine At Mount Sinai

Active Indication_Name:
Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Flotillin 1 (YP6045) Mouse mAb supplier
ICAM1 Rabbit mAb manufacturer
Histone H3 (acetyl K18) Antibody: Histone H3 (acetyl K18) Antibody is a non-conjugated and Mouse origined monoclonal antibody about 15 kDa, targeting to Histone H3 (acetyl K18). It can be used for WB,IHC-P assays with tag free, in the background of Human, Rat.

Author: Betaine hydrochloride

Related Posts